Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,049 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients

NCT02812706

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Investigational Site Number :392001 Nagoya, Aichi-ken, Japan
  • Investigational Site Number :392005 Shibukawa-shi, Gunma, Japan
  • Investigational Site Number :392010 Hiroshima, Japan
  • Investigational Site Number :392015 Kanazawa, Ishikawa-ken, Japan
View all 13 locations
View Trial Details
Completed

Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

NCT02891811

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Innsbruck, Austria
  • Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Kufstein, Austria
  • LKH Hochsteiermark - Standort Leoben Abteilung für Innere Medizin und Hämatologie und internistische Onkologie Leoben, Austria
View all 21 locations
View Trial Details
Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

NCT03329950

Conditions
Adenocarcinoma, Adnexal Diseases, Bile Duct Diseases, +120 more
Locations
  • HonorHealth Research Insititute Scottsdale, Arizona, United States
  • Northside Hospital, Inc. Atlanta, Georgia, United States
  • Georgia Cancer Center at Augusta University Augusta, Georgia, United States
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists Omaha, Nebraska, United States
View Trial Details
Completed

Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients With Relapsed or Relapsed/Refractory Multiple Myeloma

NCT02119468

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions